pharmaceutics Article Novel Intranasal Drug Delivery: Geraniol Charged Polymeric Mixed Micelles for Targeting Cerebral Insult as a Result of Ischaemia/Reperfusion Sara M. Soliman 1, Nermin M. Sheta 1, Bassant M. M. Ibrahim 2, Mohammad M. El-Shawwa 3 and Shady M. Abd El-Halim 1,* 1 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, 6th of October University, Central Axis, Sixth of October City, Giza 12585, Egypt;
[email protected] (S.M.S.);
[email protected] (N.M.S.) 2 Department of Pharmacology, Medical Research Division, National Research Centre, Dokki, Giza 12622, Egypt;
[email protected] 3 Department of Physiology, Faculty of Medicine for Girls, Al-Azhar University, Cairo 11651, Egypt;
[email protected] * Correspondence:
[email protected]; Tel.: +20-11-199-94874 Received: 16 November 2019; Accepted: 13 January 2020; Published: 17 January 2020 Abstract: Brain damage caused by cerebral ischaemia/reperfusion (I/R) can lead to handicapping. So, the present study aims to evaluate the prophylactic and therapeutic effects of geraniol in the form of intranasal polymeric mixed micelle (PMM) on the central nervous system in cerebral ischaemia/reperfusion (I/R) injury. A 32 factorial design was used to prepare and optimize geraniol PMM to investigate polymer and stabilizer different concentrations on particle size (PS) and percent entrapment efficiency (%EE). F3 possessing the highest desirability value (0.96), with a PS value of 32.46 0.64 nm, EE of 97.85 1.90%, and release efficiency of 59.66 0.64%, was selected for ± ± ± further pharmacological and histopathological studies. In the prophylactic study, animals were classified into a sham-operated group, a positive control group for which I/R was done without treatment, and treated groups that received vehicle (plain micelles), geraniol oil, and geraniol micelles intranasally before and after I/R.